Miller School pulmonologist treats COVID-19 patient with nitric oxide therapy “could be a critical step in the fight against this pandemic due to the therapy’s potential to halt disease progression and reduce the need for ventilation support,” said Fabian Tenenbaum, CEO of Bellerophon Therapeutics.
[ad_1]
Miller School pulmonologist treats COVID-19 patient with nitric oxide therapy “could be a critical step in the fight against this pandemic due to the therapy’s potential to halt disease progression and reduce the need for ventilation support,” said Fabian Tenenbaum, CEO of Bellerophon Therapeutics.
[ad_2]
View Reddit by dannylenwinn – View Source
